Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Antonella, Diciolla"'
Autor:
Antonia Stamatiou, Jeremy Jankovic, Petr Szturz, Francois Fasquelle, Rafael Duran, Niklaus Schaefer, Antonella Diciolla, Antonia Digklia
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Arising from the biliary tract, cholangiocarcinoma is a rare and aggressive epithelial cancer. According to the primary site, it can be further classified into intrahepatic, perihilar and distal types. Due to the lack of symptoms early in the disease
Externí odkaz:
https://doaj.org/article/b2c0c81a3076466bb8a84a194747d129
Autor:
Louis Gros, Petr Szturz, Antonella Diciolla, Volker Kirchner, Solange Peters, Niklaus Schaefer, Martin Hubner, Antonia Digklia
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The prognosis is often very
Externí odkaz:
https://doaj.org/article/ee69a0887d2249ad8141abed71019fa8
Autor:
Carole Bandiera, Evelina Cardoso, Isabella Locatelli, Antonia Digklia, Khalil Zaman, Antonella Diciolla, Valérie Cristina, Athina Stravodimou, Aedo Lopez Veronica, Ana Dolcan, Apostolos Sarivalasis, Aikaterini Liapi, Hasna Bouchaab, Angela Orcurto, Jennifer Dotta-Celio, Solange Peters, Laurent Decosterd, Nicolas Widmer, Dorothea Wagner, Chantal Csajka, Marie Paule Schneider
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 6, p e30090 (2021)
BackgroundThe strengthening or substitution of intravenous cytotoxic chemotherapy cycles by oral targeted anticancer therapies, such as protein kinase inhibitors (PKIs), has provided impressive clinical benefits and autonomy as well as a better quali
Externí odkaz:
https://doaj.org/article/04775837df1f491490dee20da4b49c14
Autor:
Tu Nguyen-Ngoc, Karim Abdelhamid, Nils Degrauwe, Sabine Galland, Andrea Serena, Melissa Christofis, Nuria Mederos, Hasna Bouchaab, Antonella Diciolla, Nassim Dris, Angela Orcurto, Claire Perrinjaquet, Marc Schnetz, Sofiya Latifyan, Laureline Wetterwald, Ruth Gabriela Herrera Gómez, Valérie Cristina, Apostolos Sarivalasis, Olivier Michielin, Dominik Berthold, Antonia Digklia, Anna Dorothea Wagner, Khalil Zaman, Solange Peters, Athina Stravodimou
Publikováno v:
Revue Médicale Suisse. 19:52-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b36853729eba92fe90735f2e731077a0
https://doi.org/10.53738/revmed.2023.19.809-10.52
https://doi.org/10.53738/revmed.2023.19.809-10.52
Autor:
Manuela Undurraga, Patrice Mathevet, Martin Hubner, Nicolas C. Buchs, Maxime Warlaumont, Apostolos Sarivalasis, Antonella Diciolla, Noémie Lang, Thibaud Koessler, Antonia Digklia, Frédéric Ris, Patrick Petignat, Intidhar Labidi-Galy
Publikováno v:
Revue Médicale Suisse. 18:990-996
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::636f7823bff001a557985043554ebf20
https://doi.org/10.53738/revmed.2022.18.782.990
https://doi.org/10.53738/revmed.2022.18.782.990
Autor:
Giovanni Dei Tos, Ilianna Galli Vareia, Alexandre Huber, Benita Wolf, Antonella Diciolla, Ruth Gabriela Herrera Gomez, Dorothea Wagner, Antonia Digklia, Hasna Bouchaab, Valérie Cristina, Athina Stravodimou, Khalil Zaman, Apostolos Sarivalasis, Dominik Berthold, Solange Peters, Claire Perrinjaquet, Jonas Kloepper, Jeremy Jankovic
Publikováno v:
Revue Médicale Suisse. 17:201-205
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c0df38ce3a00fbee4a7a990d9805c76
https://doi.org/10.53738/revmed.2021.17.723.0201
https://doi.org/10.53738/revmed.2021.17.723.0201
Autor:
Manuela, Undurraga, Patrice, Mathevet, Martin, Hubner, Nicolas C, Buchs, Maxime, Warlaumont, Apostolos, Sarivalasis, Antonella, Diciolla, Noémie, Lang, Thibaud, Koessler, Antonia, Digklia, Frédéric, Ris, Patrick, Petignat, Intidhar, Labidi-Galy
Publikováno v:
Revue medicale suisse. 18(782)
Ovarian cancer is the first cause of death by gynecological cancer. Most of the patients are diagnosed with peritoneal carcinomatosis that represents a therapeutic challenge. Its management implies maximal cytoreductive surgery with survival benefit.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::86677b1c4cce12d8852be512fcfcc481
https://pubmed.ncbi.nlm.nih.gov/35583278
https://pubmed.ncbi.nlm.nih.gov/35583278
Autor:
Anastasia Vernadou, Nabila Ferahta, Nuria Mederos, Daniela Ferraro, Irma Dischl-antonioni, Antonella Diciolla, Aikaterini Liapi, Valerie Mosimann, Sofiya Latifyan, Veronica Aedo-lopez, Dominik Berthold, Antonia Digklia, Olivier Michielin, Michael Montemurro, Anna Dorothea Wagner, Khalil Zaman, Solange Peters, Athina Stravodimou, Apostolos Sarivalasis
Publikováno v:
Revue Médicale Suisse. 16:72-77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84bece67789200345d2e54801791747f
https://doi.org/10.53738/revmed.2020.16.676-77.0072
https://doi.org/10.53738/revmed.2020.16.676-77.0072
Autor:
Solange Peters, Niklaus Schaefer, Louis Gros, Antonella Diciolla, Martin Hübner, Petr Szturz, Antonia Digklia, Volker Kirchner
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in oncology, vol. 11, pp. 704295
Frontiers in Oncology
Frontiers in oncology, vol. 11, pp. 704295
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The prognosis is often very
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335cdff90e2cabca9358f9e54256d316
https://www.frontiersin.org/articles/10.3389/fonc.2021.704295/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.704295/full
Autor:
Carole Bandiera, Evelina Cardoso, Isabella Locatelli, Antonia Digklia, Khalil Zaman, Antonella Diciolla, Valérie Cristina, Athina Stravodimou, Aedo Lopez Veronica, Ana Dolcan, Apostolos Sarivalasis, Aikaterini Liapi, Hasna Bouchaab, Angela Orcurto, Jennifer Dotta-Celio, Solange Peters, Laurent Decosterd, Nicolas Widmer, Dorothea Wagner, Chantal Csajka, Marie Paule Schneider
BACKGROUND The strengthening or substitution of intravenous cytotoxic chemotherapy cycles by oral targeted anticancer therapies, such as protein kinase inhibitors (PKIs), has provided impressive clinical benefits and autonomy as well as a better qual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::479c80c58ccf09ae5dff44be1fdb3549
https://doi.org/10.2196/preprints.30090
https://doi.org/10.2196/preprints.30090
